These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 3815357)
1. Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Greig NH; Momma S; Sweeney DJ; Smith QR; Rapoport SI Cancer Res; 1987 Mar; 47(6):1571-6. PubMed ID: 3815357 [TBL] [Abstract][Full Text] [Related]
2. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain. Cornford EM; Young D; Paxton JW; Finlay GJ; Wilson WR; Pardridge WM Cancer Res; 1992 Jan; 52(1):138-43. PubMed ID: 1727374 [TBL] [Abstract][Full Text] [Related]
3. Regional cerebrovascular transport of leucine as measured by the in situ brain perfusion technique. Smith QR; Takasato Y; Sweeney DJ; Rapoport SI J Cereb Blood Flow Metab; 1985 Jun; 5(2):300-11. PubMed ID: 3988829 [TBL] [Abstract][Full Text] [Related]
4. Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier. Takada Y; Vistica DT; Greig NH; Purdon D; Rapoport SI; Smith QR Cancer Res; 1992 Apr; 52(8):2191-6. PubMed ID: 1559223 [TBL] [Abstract][Full Text] [Related]
5. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma. Groothuis DR; Lippitz BE; Fekete I; Schlageter KE; Molnar P; Colvin OM; Roe CR; Bigner DD; Friedman HS Cancer Res; 1992 Oct; 52(20):5590-6. PubMed ID: 1394182 [TBL] [Abstract][Full Text] [Related]
6. Evidence for carrier-mediated transport of melphalan by L5178Y lymphoblasts in vitro. Goldenberg GJ; Lee M; Lam HY; Begleiter A Cancer Res; 1977 Mar; 37(3):755-60. PubMed ID: 837375 [TBL] [Abstract][Full Text] [Related]
7. Transport of amantadine and rimantadine through the blood-brain barrier. Spector R J Pharmacol Exp Ther; 1988 Feb; 244(2):516-9. PubMed ID: 3346834 [TBL] [Abstract][Full Text] [Related]
8. Cerebral amino acid levels and uptake in rats after portocaval anastomosis: II. Regional studies in vivo. Zanchin G; Rigotti P; Dussini N; Vassanelli P; Battistin L J Neurosci Res; 1979; 4(4):301-10. PubMed ID: 469965 [TBL] [Abstract][Full Text] [Related]
9. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier. Tsuji A; Saheki A; Tamai I; Terasaki T J Pharmacol Exp Ther; 1993 Dec; 267(3):1085-90. PubMed ID: 8263769 [TBL] [Abstract][Full Text] [Related]
10. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat. Duncan MW; Villacreses NE; Pearson PG; Wyatt L; Rapoport SI; Kopin IJ; Markey SP; Smith QR J Pharmacol Exp Ther; 1991 Jul; 258(1):27-35. PubMed ID: 2072299 [TBL] [Abstract][Full Text] [Related]
11. Nutrient transport and the blood-brain barrier in developing animals. Cornford EM; Cornford ME Fed Proc; 1986 Jun; 45(7):2065-72. PubMed ID: 2872083 [TBL] [Abstract][Full Text] [Related]
12. "Facilitated" amino acid transport is upregulated in brain tumors. Miyagawa T; Oku T; Uehara H; Desai R; Beattie B; Tjuvajev J; Blasberg R J Cereb Blood Flow Metab; 1998 May; 18(5):500-9. PubMed ID: 9591842 [TBL] [Abstract][Full Text] [Related]
13. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier. Poduslo JF; Curran GL; Haggard JJ; Biere AL; Selkoe DJ Neurobiol Dis; 1997; 4(1):27-34. PubMed ID: 9258909 [TBL] [Abstract][Full Text] [Related]
14. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier. Reichel A; Begley DJ; Abbott NJ J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805 [TBL] [Abstract][Full Text] [Related]
15. Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L. Mokrzan EM; Kerper LE; Ballatori N; Clarkson TW J Pharmacol Exp Ther; 1995 Mar; 272(3):1277-84. PubMed ID: 7891344 [TBL] [Abstract][Full Text] [Related]
16. Large neutral amino acid transporter enables brain drug delivery via prodrugs. Gynther M; Laine K; Ropponen J; Leppänen J; Mannila A; Nevalainen T; Savolainen J; Järvinen T; Rautio J J Med Chem; 2008 Feb; 51(4):932-6. PubMed ID: 18217702 [TBL] [Abstract][Full Text] [Related]
17. The transport of leucine and aminocyclopentanecarboxylate across the intact, energy-depleted rat blood-brain barrier. Greenwood J; Hazell AS; Pratt OE J Cereb Blood Flow Metab; 1989 Apr; 9(2):226-33. PubMed ID: 2921297 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of amino acid transport at the blood-brain barrier studied using an in situ brain perfusion technique. Smith QR; Takasato Y Ann N Y Acad Sci; 1986; 481():186-201. PubMed ID: 3468857 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of regional blood-brain barrier transport of L-leucine in Brattleboro rats. Brust P; Zicha J Biomed Biochim Acta; 1988; 47(12):1013-21. PubMed ID: 3254149 [TBL] [Abstract][Full Text] [Related]
20. A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino-acid-containing anticancer agents. Killian DM; Chikhale PJ J Neurochem; 2001 Feb; 76(4):966-74. PubMed ID: 11181816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]